Healio

Deferred IOL implantation leads to better outcomes in traumatic pediatric cataract

Primary IOL implantation in pediatric open globe injuries with active inflammation showed inferior visual outcomes compared ...
Medical Device and Diagnostic Industry (MD+DI)

FDA Approves Johnson & Johnson's Breakthrough Cataracts Solution

The Tecnis PureSee IOL is the first FDA-approved extended depth of focus IOL maintaining contrast sensitivity comparable to ...
MassDevice

Johnson & Johnson wins FDA nod for new intraocular lens

Johnson & Johnson (NYSE: JNJ) announced that it received FDA approval for its Tecnis PureSee intraocular lens (IOL) for cataract surgery.
Healio

Outlook is bright for refractive cataract surgery

Please provide your email address to receive an email when new articles are posted on . This issue’s cover story on refractive cataract surgery is timely. The American Society of Cataract and ...
Nature

Cataract Surgery and Intraocular Lens Power Calculation

Cataract surgery remains one of the most frequently performed and successful surgical procedures worldwide, involving the removal of a clouded natural lens and its replacement with an intraocular lens ...
GlobalData on MSN

FDA approves J&J’s TECNIS PureSee intraocular lens

The TECNIS PureSee IOL addresses both cataract-related vision loss and presbyopia, which affects near vision as eyes age.